Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight With Comorbidity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04232774
What this trial is testing

Neurotronic Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

Who this might be right for
Type 2 Diabetes Mellitus With Circulatory Complciation
Neurotronic, Inc. 22
Large-scale testing (Phase 3)Study completedNCT00386061
What this trial is testing

Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)

Who this might be right for
Obesity
Sanofi 1,507
Post-approval studies (Phase 4)Study completedNCT00983970
What this trial is testing

Effects of Interactive Video Game Cycling on Obese Adolescent Health

Who this might be right for
Overweight With ComorbidityObesity
Children's Hospital of Eastern Ontario 30
Not applicableEnrolling By InvitationNCT07736547
What this trial is testing

AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss

Who this might be right for
Overweight (Without Type 2 Diabetes) With Weight-related ComorbiditiesOverweight (BMI > 25)
Varol TUNALI 80
Testing effectiveness (Phase 2)Looking for participantsNCT07467447
What this trial is testing

Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

Who this might be right for
Obesity
Hudson Biotech 300
Testing effectiveness (Phase 2)Study completedNCT07002905
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
Chronic Weight Management
Ascletis Pharma (China) Co., Limited 125
Testing effectiveness (Phase 2)Study completedNCT06277934
What this trial is testing

RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
Obesity
Regor Pharmaceuticals Inc. 73
Large-scale testing (Phase 3)Study completedNCT05024032
What this trial is testing

Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)

Who this might be right for
ObesityOverweightMetabolism and Nutrition Disorder
Eli Lilly and Company 210
Not applicableStudy completedNCT05756361
What this trial is testing

Family-Based Treatment for Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Obesity, ChildhoodOverweight+1 more
State University of New York at Buffalo 22
Not applicableStudy completedNCT04670094
What this trial is testing

Comorbidities and Risk Score in COVID-19 Patients

Who this might be right for
Covid19
University of Milano Bicocca 4,555
Testing effectiveness (Phase 2)Study completedNCT06579092
What this trial is testing

Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity

Who this might be right for
Obesity or Overweight
AstraZeneca 310
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07292519
What this trial is testing

Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)

Who this might be right for
Alcohol Use Disorder (AUD)Overweight or ObeseComorbidities and Coexisting Conditions
South West Sydney Local Health District 46
Not applicableStudy completedNCT01686997
What this trial is testing

Effect of Long Biliopancreatic Limb RYGB on Weight Loss and Comorbidities

Who this might be right for
Morbid Obesity
Rijnstate Hospital 280
Testing effectiveness (Phase 2)Looking for participantsNCT07752979
What this trial is testing

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweight
AbbVie 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT07497880
What this trial is testing

Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

Who this might be right for
ObesityOverweight
Kailera 306
Not applicableStudy completedNCT04507867
What this trial is testing

Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III

Who this might be right for
COVID19Diabetes MellitusHypertension+5 more
Anahuac University 80
Large-scale testing (Phase 3)Looking for participantsNCT07784725
What this trial is testing

Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Who this might be right for
Obesity or Overweight
AstraZeneca 2,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06965413
What this trial is testing

Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

Who this might be right for
ObesityOverweightOverweight With One Weight Related Comorbidity
Hoffmann-La Roche 285
Large-scale testing (Phase 3)Looking for participantsNCT07284875
What this trial is testing

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Who this might be right for
ObesityOverweight
Kailera 2,340
Large-scale testing (Phase 3)Study completedNCT06047548
What this trial is testing

LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
OverweightObesity
Eli Lilly and Company 441
Next Page